Tumor and immune cell distribution in the tumor core and outer part of glioblastoma, IDH wildtype
Journal of Neuro-Oncology · 2025
DOI: 10.1007/s11060-025-05232-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuro-Oncology, 2025. Verfasst von Vilde Pedersen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Bartholin Institute, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. vilde.pedersen@regionh.dk. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Isocitrate Dehydrogenase, Lymphocytes, Tumor-Infiltrating. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Hospital.
Abstract (Originalsprache)
Purpose
Glioblastoma, IDH-wildtype is the most frequent and malignant primary brain tumor in adults. Tumor cells infiltrate the brain parenchyma, preventing complete resection and causing progression. Immune therapies have limited effect, but little is known about the frequency and type of immune cells in the outer part of glioblastoma, IDH-wildtype, where tumor cells start to infiltrate the brain (transition zone) and diffusely infiltrate the brain parenchyma (tumor periphery). We aimed to quantify the type and distribution of immune cells in glioblastomas, IDH-wildtype covering these areas.
Methods
We established a cohort of 54 glioblastomas, IDH-wildtype containing tissue from the tumor core, transition zone, and periphery. Patients were included if most tumor cells were positive in immunohistochemical staining for P53. Tissue sections were subject to multiplex immunohistochemistry and stained with P53 (tumor), FOXP3 (regulatory T cells), CD8 (cytotoxic T cells), and IBA1 (microglia/macrophages). A software-based classifier was trained to count the cells.
Results
The densities of CD8+, FOXP3+, and IBA1+ cells were significantly higher in the core than in the periphery and in the transition zone than in the periphery. However, the CD8+, FOXP3+, and IBA1+ cell/tumor cell ratio increased from the core to the transition zone, and the CD8+ and IBA1+ cell/tumor cell ratio increased again to the periphery. The core had the highest FOXP3+/CD8+ ratio, as well as the highest fraction of tumor cells with IBA1+ cells, CD8+ cells, and FOXP3+ cells in proximity.
Conclusion
This study highlights spatial differences in the immune microenvironment with potential implications for future immune-therapeutic strategies. Graphical abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, The Bartholin Institute, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. vilde.pedersen@regionh.dk.
- Department of Clinical Medicine and Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark. vilde.pedersen@regionh.dk.
- DCCC Brain Tumor Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. vilde.pedersen@regionh.dk.
- Department of Pathology, Odense University Hospital, Odense, Denmark.
- Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
- Department of Pathology, The Bartholin Institute, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Förderung
- National Hospital
Zitieren
APA
Pedersen, V., Knudsen, A. M., Michaelsen, S. R., Dahlrot, R. H., & Kristensen, B. W. (2025). Tumor and immune cell distribution in the tumor core and outer part of glioblastoma, IDH wildtype. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-025-05232-5
Vancouver
Pedersen V, Knudsen AM, Michaelsen SR, Dahlrot RH, Kristensen BW. Tumor and immune cell distribution in the tumor core and outer part of glioblastoma, IDH wildtype. Journal of Neuro-Oncology. 2025. doi:10.1007/s11060-025-05232-5
BibTeX
@article{Pedersen2025,
author = {Pedersen, Vilde and Knudsen, Arnon Møldrup and Michaelsen, Signe Regner and Dahlrot, Rikke Hedegaard and Kristensen, Bjarne Winther},
title = {Tumor and immune cell distribution in the tumor core and outer part of glioblastoma, IDH wildtype},
journal = {Journal of Neuro-Oncology},
year = {2025},
doi = {10.1007/s11060-025-05232-5}
}
EUVIMED